Search

PROCEPT BioRobotics Corp

Fermé

SecteurSoins de santé

21.65 -0.73

Résumé

Variation du prix de l'action

24h

Actuel

Min

21.35

Max

21.9

Chiffres clés

By Trading Economics

Revenu

-27M

-58M

Ventes

11M

94M

BPA

-0.47

Marge bénéficiaire

-61.905

Employés

888

EBITDA

5.1M

-24M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+6.84% upside

Dividendes

By Acuity

Prochains Résultats

3 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

197M

1.2B

Ouverture précédente

22.38

Clôture précédente

21.65

Sentiment de l'Actualité

By Acuity

50%

50%

163 / 340 Classement par Healthcare

PROCEPT BioRobotics Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 août 2026, 19:46 UTC

News

Procept Biorobotics faces class action lawsuits alleging securities fraud, leading shares to decline during Friday's session after earlier reaching a high.

13 août 2026, 20:06 UTC

Procept Biorobotics Corp is gaining during Thursday's session, following strong momentum and peaking at 7.26% earlier, despite a pullback in recent trading.

12 août 2026, 20:01 UTC

News

Procept Biorobotics shares are lower amid a class action lawsuit alleging securities fraud related to undisclosed inventory issues and misleading sales practices.

11 août 2026, 20:02 UTC

Procept Biorobotics Corp shares are higher today, marking the seventh consecutive session of gains. No specific news was identified to explain the increase.

10 août 2026, 19:53 UTC

Procept Biorobotics Corp shares are higher, supported by reduced Fed rate hike expectations following Friday's weaker jobs report. The stock remains above its 20-day moving average.

7 août 2026, 20:02 UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

6 août 2026, 20:03 UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

5 août 2026, 19:52 UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

4 août 2026, 23:02 UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

3 août 2026, 20:03 UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

31 juil. 2026, 20:02 UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

30 juil. 2026, 19:58 UTC

Procept Biorobotics Corp is rising during Thursday's session, driven by a broader market rally and recovery in technology shares. No specific company news was identified.

29 juil. 2026, 16:26 UTC

Procept Biorobotics Corp shares are higher Wednesday, recovering from earlier losses amid broader market volatility ahead of the Federal Reserve's interest rate decision.

28 juil. 2026, 19:26 UTC

Procept Biorobotics Corp shares are trading higher, reflecting a cumulative gain since Monday, despite negative sentiment from declines in Asian markets.

27 juil. 2026, 17:02 UTC

News

Procept Biorobotics reported Q1 revenue of $83.1 million, a 20% increase. Shares are trading higher, recovering from recent declines since Friday's close.

22 juil. 2026, 19:41 UTC

Procept Biorobotics Corp shares are lower today, diverging from recent gains. Broader market concerns include rising crude oil prices and inflationary pressures.

21 juil. 2026, 16:01 UTC

Procept Biorobotics Corp is declining during Tuesday's session, breaking a trend of higher daily closes. No specific news was identified for the move.

20 juil. 2026, 19:56 UTC

Procept Biorobotics Corp shares are higher today, despite earlier volatility and no specific news. Broader market performance remains mixed amid geopolitical tensions.

Comparaison

Variation de prix

PROCEPT BioRobotics Corp prévision

Objectif de Prix

By TipRanks

6.84% hausse

Prévisions sur 12 Mois

Moyen 23.13 USD  6.84%

Haut 29 USD

Bas 19 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

11 ratings

3

Achat

7

Maintien

1

Vente

Sentiment

By Acuity

163 / 340Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat